Osaic Holdings’s Tema Oncology ETF CANC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.7K Buy
470
+100
+27% +$4.23K ﹤0.01% 6207
2026
Q2
$15.3K Hold
370
– – ﹤0.01% 6363
2026
Q1
$13.6K Hold
370
– – ﹤0.01% 6114
2025
Q4
$12.8K Hold
370
– – ﹤0.01% 6177
2025
Q3
$10.6K Hold
370
– – ﹤0.01% 6323
2025
Q2
$9.15K Hold
370
– – ﹤0.01% 6212
2025
Q1
$8.91K Buy
+370
New +$9.31K ﹤0.01% 5850
2024
Q4
– Sell
-200
Closed -$5.68K – 7427
2024
Q3
$5.68K Hold
200
– – ﹤0.01% 6137
2024
Q2
$5.4K Hold
200
– – ﹤0.01% 6128
2024
Q1
$5.62K Buy
200
+50
+33% +$1.36K ﹤0.01% 6028
2023
Q4
$3.96K Buy
+150
New +$3.53K ﹤0.01% 6257

Other funds holding CANC

Osaic Holdings's CANC Position: Q3 2026 in Review

Osaic Holdings increased its Tema Oncology ETF (CANC) stake by 27% in Q3 2026, buying an estimated $4.23K and bringing the position to 470 shares worth $19.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6207.

Osaic Holdings first reported a position in CANC in Q4 2023 and has held it in 11 quarters since. 17 funds tracked by Wall St. Rank hold CANC as of Q3 2026.

  • Osaic Holdings held 470 shares of Tema Oncology ETF worth $19.7K as of Q3 2026.
  • Osaic Holdings bought 100 Tema Oncology ETF shares in Q3 2026, an estimated $4.23K.
  • Tema Oncology ETF made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #6207 holding.
  • Osaic Holdings first reported a position in Tema Oncology ETF in Q4 2023 and has held it in 11 quarters since.
  • 17 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.